From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer
Crossref DOI link: https://doi.org/10.1186/s13048-024-01359-7
Published Online: 2024-02-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Zesi
Jing, Chunli
Kong, Fandou
Text and Data Mining valid from 2024-02-12
Version of Record valid from 2024-02-12
Article History
Received: 5 July 2023
Accepted: 26 January 2024
First Online: 12 February 2024
Declarations
:
: Not applicable.
: The authors declare no competing interests.